eMedicine Specialties > Emergency Medicine > Toxicology

Toxicity, Medication-Induced Dystonic Reactions: Treatment & Medication

Author: Geofrey Nochimson, MD, Consulting Staff, Department of Emergency Medicine, Sentara Careplex Hospital
Contributor Information and Disclosures

Updated: Dec 14, 2009

Treatment

Emergency Department Care

  • Emergency interventions other than pharmacologic treatment rarely are required.
  • Securing the airway is necessary only rarely, when laryngeal and pharyngeal dystonic reactions place the patient at risk of imminent respiratory arrest.
  • Pharmacologic treatment resolves the reaction.

Medication

The goals of pharmacotherapy are to reduce morbidity and prevent complications.

Anticholinergic agents

Intravenous anticholinergic agents are the treatment of choice. IV is the route of choice, with signs and symptoms often resolving within 10 minutes. The medication can be delivered IM if an IV line cannot be established, but medications will take 30 min to be absorbed. More than 1 dose may be necessary for complete resolution of dystonia.


Benztropine (Cogentin)

By blocking striatal cholinergic receptors, may help in balancing cholinergic and dopaminergic activity.

Adult

1-2 mg PO/IV/IM qd or bid; IV has most rapid onset

Pediatric

<3 years: Not established
>3 years: 0.02-0.05 mg/kg PO/IV/IM; not to exceed 2 mg/d

Decreases effects of levodopa; increases effects of narcotic analgesics, phenothiazines, quinidine, tricyclic antidepressants, and anticholinergics

Documented hypersensitivity; angle-closure glaucoma; stenosing peptic ulcers; prostatic hypertrophy or bladder neck obstructions; myasthenia gravis; pyloric or duodenal obstruction; achalasia (megaesophagus); megacolon

Pregnancy

C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus

Precautions

May exacerbate hypertension, tachycardia, cardiac arrhythmias, liver or kidney disorders, hypotension, prostatic hypertrophy, urinary retention, and obstructive disease of GI/GU tracts; may cause toxic psychosis in psychiatric patients with extrapyramidal reactions resulting from phenothiazine


Diphenhydramine (Benadryl)

Although an antihistamine, also possesses significant anticholinergic properties. Mechanism of action is identical to that of benztropine.

Adult

50-100 mg IV/IM repeat prn

Pediatric

1-2 mg/kg IV/IM repeat prn

Potentiates effect of CNS depressants; alcohol content of syrup dosage form may cause disulfiramlike reaction in patients taking medications that can cause these reactions

Documented hypersensitivity; MAOIs; angle-closure glaucoma

Pregnancy

A - Fetal risk not revealed in controlled studies in humans

Precautions

May exacerbate angle-closure glaucoma, hyperthyroidism, peptic ulcer, and urinary tract obstruction

Benzodiazepines

Normal balance between dopamine and acetylcholine in the basal ganglia involves modulation from GABA-containing striatonigral neurons. GABA-ergic neurons are inhibitory and antagonize excitatory dopaminergic neurons. GABA agonists (eg, benzodiazepines) may be helpful for acute dystonic reactions.


Diazepam (Valium)

Some recommend using for patients with dystonic reactions refractory to anticholinergic therapy or when such therapy is contraindicated.

Adult

2.5-10 mg IV slow push

Pediatric

0.1 mg/kg IV slow push repeat prn

Phenothiazines, barbiturates, alcohols, and MAOIs may increase CNS toxicity

Documented hypersensitivity; narrow-angle glaucoma

Pregnancy

X - Contraindicated; benefit does not outweigh risk

Precautions

Caution with other CNS depressants, low albumin levels, or hepatic disease (may increase toxicity)

More on Toxicity, Medication-Induced Dystonic Reactions

Overview: Toxicity, Medication-Induced Dystonic Reactions
Differential Diagnoses & Workup: Toxicity, Medication-Induced Dystonic Reactions
Treatment & Medication: Toxicity, Medication-Induced Dystonic Reactions
Follow-up: Toxicity, Medication-Induced Dystonic Reactions
References

References

  1. Fahn S. The varied clinical expressions of dystonia. Neurol Clin. Aug 1984;2(3):541-54. [Medline].

  2. Marsden CD, Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med. Feb 1980;10(1):55-72. [Medline].

  3. McCormick MA, Manoguerra AS. Dystonic reaction. In: Harwood-Nuss A, et al, eds. Clinical Practice of Emergency Medicine. Lippincott Williams & Wilkins; 1991:510-511.

  4. Fines RE, Brady WJ, DeBehnke DJ. Cocaine-associated dystonic reaction. Am J Emerg Med. Sep 1997;15(5):513-5. [Medline].

  5. Kumor K. Cocaine withdrawal dystonia. Neurology. May 1990;40(5):863-4. [Medline].

  6. Barach E, Dubin LM, Tomlanovich MC, Kottamasu S. Dystonia presenting as upper airway obstruction. J Emerg Med. May-Jun 1989;7(3):237-40. [Medline].

  7. Demetropoulos S, Schauben JL. Acute dystonic reactions from "street Valium". J Emerg Med. Jul-Aug 1987;5(4):293-7. [Medline].

  8. Elliott ES, Marken PA, Ruehter VL. Clozapine-associated extrapyramidal reaction. Ann Pharmacother. May 2000;34(5):615-8. [Medline].

  9. Herrstedt J. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting. Expert Opin Drug Saf. May 2004;3(3):231-48. [Medline].

  10. Jhee SS, Zarotsky V, Mohaupt SM, et al. Delayed onset of oculogyric crisis and torticollis with intramuscular haloperidol. Ann Pharmacother. Oct 2003;37(10):1434-7. [Medline].

  11. Piecuch S, Thomas U, Shah BR. Acute dystonic reactions that fail to respond to diphenhydramine: think of PCP. J Emerg Med. May-Jun 1999;17(3):527. [Medline].

  12. Roberge RJ. Antiemetic-related dystonic reaction unmasked by removal of a scopolamine transdermal patch. J Emerg Med. Apr 2006;30(3):299-302. [Medline].

  13. Schumock GT, Martinez E. Acute oculogyric crisis after administration of prochlorperazine. South Med J. Mar 1991;84(3):407-8. [Medline].

Further Reading

Keywords

medication-induced dystonic reactions, dystonic reaction, neuroleptic drug therapy, drug treatment, neuroleptics, neuroleptic agents, dyskinesia, acute dystonic reaction, neuroleptic drugs, involuntary muscle contractions

Contributor Information and Disclosures

Author

Geofrey Nochimson, MD, Consulting Staff, Department of Emergency Medicine, Sentara Careplex Hospital
Geofrey Nochimson, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Nothing to disclose.

Medical Editor

Samuel M Keim, MD, Associate Professor, Department of Emergency Medicine, University of Arizona College of Medicine
Samuel M Keim, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Public Health Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Michael J Burns, MD, Instructor, Department of Emergency Medicine, Harvard University Medical School, Beth Israel Deaconess Medical Center
Michael J Burns, MD is a member of the following medical societies: American Academy of Clinical Toxicology, American College of Emergency Physicians, American College of Medical Toxicology, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Asim Tarabar, MD, Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.